Horn & Co. is the leading Israeli boutique law firm in the field of hi-tech and life sciences and is unique in its exclusive practice and expertise in this field. The firm’s founder, Yuval Horn, was recognized by the International Who’s Who of Life Sciences Lawyers as a Global Thought Leader (2018, 2019, 2020) and as one of the five leading individuals in the world in life sciences transactions (2013, 2015).
Horn & Co. was founded in September 2009 and is known for its tailored, innovative structures, solutions and advice in complex transactions and situations. Since 1993, we have represented numerous founders, companies, and investors in their transactions in the life science and technology sectors. Recent examples include the representation of Anima Biotech in a license and development agreement with Illy Lilly with an aggregate deal value of over one billion dollars; INX Ltd. in the submission to the SEC of the first prospectus covering the issuance of security tokens; cCAM Biotherapeutics Ltd. In the acquisition by Merck & Co. for $ 605 million, Taboola.com in one of the largest private financing rounds of an Israeli company ($130 million); the formation and representation of Pontifax 6 L.P. and Pontifax Venture Lending, both managed by Pontifax Venture Capital group, Israel’s most prominent life sciences designated investment fund and Diagnostic Robotics Ltd. in its strategic agreements (including the Israeli MOH).
Horn & Co. is the Israeli member of Biolegis (www.biolegis.com), a network of leading European law firms with specific expertise in the representation of biotechnology and medical device companies. The firm’s partners and associates have been recognized by the leading international publications and peers as experts in corporate law, intellectual property and technology transactions and are typically asked to lecture and write about these areas. Horn & Co. has been recognized by Legal 500 as a “Tier 1” firm in Israel in the field of Healthcare and Life Sciences noting that: “the firm has been active at the ‘top-level’ in the healthcare sector for over 20 years”.
The firm has been consistently selected by Iam Magazine (Intellectual Asset Management) as one of the top 5 “highly recommended” Israeli firms in the field of intellectual property transactions, stating that “Horn & Co is in its element when commercializing intellectual property; its finely-honed business instincts ensure that it can identify the best routes to maximize portfolio value”.” It is one of two firms that boast 3 practitioners as leading in the field. Since 2008 Yuval has been a member and legal advisor of the Institutional Review Board (Helsinki Committee) of the Chaim Sheba Medical Center at Tel-Hashomer. Yuval served as the Co-Chair of the International Bar Association (IBA) Technology Law Committee (2016-2017), is Co-Chair of the IBA Annual World Life Sciences Conference and of the IBA Annual M&A in the Technology Sector Conference.
iam Magazin 2015– Licensing
Horn & Co. listed by iam Magazine (Intellectual Asset Management) as one of the top 6 recommended Israeli firms in the field of Licensing.(June 2015)
Who's Who Legal 2015 – Life Sciences
Yuval Horn noted as one of 5 most highly regarded practitioners worldwide in life sciences transactions.
iam Magazin 2014- Intellectual Asset Management
Horn & Co. listed by iam Magazine (Intellectual Asset Management) as one of the top 6 recommended Israeli firms in the field of IP transactions. (June 2014)
iam Magazin 2013- Intellectual Asset Management
Horn & Co. listed by iam Magazine (Intellectual Asset Management) as one of the top 6 recommended Israeli firms in the field of Licensing. (August 2013)
Investments Tower, Weizmann St. 2, Floor 24, Tel Aviv 6423902
Our specialist Yuval Horn is happy to meet you.